Lung epithelial-C/EBPβ contributes to LPS-induced inflammation and its suppression by formoterol

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary

Klaus F. Rabe · American Journal of Respiratory and Critical Care Medicine · 2007 · 2.6K citations

Medicine, Chronic Disease Prevention, Preventive Medicine +15

Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers

Mona Bafadhel, Susan McKenna, Sarah Terry et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 1.1K citations

Medicine, Clinical Sciences, Internal Medicine +17

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

W Szafrański, Alberto Cukier, Ana Sofia Ramírez et al. · European Respiratory Journal · 2003 · 889 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.

Åke Ryrfeldt, Paul Andersson, Staffan Edsbäcker et al. · PubMed · 1982 · 301 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Interaction between glucocorticoids and β 2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

Michael Roth, Peter R. A. Johnson, Jochen J. Rüdiger et al. · The Lancet · 2002 · 269 citations

Life Sciences, Pharmacology, Physiology +14